Approximately $ 123 billion worth of products are at risk of loosing patents by 2012. Even at a conservative estimate of 15 per cent opportunity, this translates into 18.4 billion dollars opportunity for generics driven Indian drug industry, according to a report of an inter-ministerial task force headed by a Joint Secretary of the Commerce Ministry.
Read Further
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment